SAN DIEGO, CA -- SpectraScience, Inc., a San Diego-based medical device company, has signed an exclusive five-year agreement with PENTAX Europe GmbH to distribute its WavSTAT Optical Biopsy System for use in colorectal cancer screening and diagnosis.
The agreement, which includes the both the new WavSTAT4 mobile console and the disposable optical biopsy forceps, covers Europe as well as Turkey, Saudi Arabia, and South Africa. The distribution agreement will provide for minimum purchase quantities in specified countries and also gives Pentax a right of first refusal option for all other countries in the Middle East and Africa.
"We are delighted to have Pentax as our first major distribution partner for the WavSTAT System," said Michael Oliver, SpectraScience chief executive officer. "Over the past 12 months Pentax has performed extensive product and market evaluations of the WavSTAT technology, and they fully understand its potential to become the professional standard for colorectal cancer screening. We look forward to kicking off sales and marketing activities in the very near term, and we are now working closely with the Pentax organization to customize business plans for key territories."
Women Jordan Shoes
iConnectHub
Login/Register
Supplier Login















